BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

PHARMAIDSPHARMACEUTICALS01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

PHARMAIDSPHARMACEUTICALS01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
03-Apr-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Pharmaids Pharmaceuticals Ltd. (Scrip Code - 524572) are listed and permitted to trade on the Exchange w	04-Apr-2024
26-Mar-2024	BC	Shiromani Vijay (Acquisition Dated on: 19/03/2024 to 21/03/2024)	19-Mar-2024
02-Mar-2024	BC	We hereby inform that Board of Directors of the Company at its meeting held today i.e; March 02, 2024, approved the allotment of 1,28,56,578 fully paid up Equity Shares for the Consideration other th	02-Mar-2024
05-Mar-2024	BC	Shreedhar Reddy	02-Mar-2024
06-Mar-2024	BC	Gokaram Ramkrishna Balaji	02-Mar-2024

No Rights has been declared by PHARMAIDSPHARMACEUTICALS

Book Closure

Record Date	Split Date	Purpose
04-Apr-2024	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Pharmaids Pharmaceuticals Ltd. (Scrip Code - 524572) are listed and permitted to trade on the Exchange w
19-Mar-2024	-	Shiromani Vijay (Acquisition Dated on: 19/03/2024 to 21/03/2024)
02-Mar-2024	-	We hereby inform that Board of Directors of the Company at its meeting held today i.e; March 02, 2024, approved the allotment of 1,28,56,578 fully paid up Equity Shares for the Consideration other th
02-Mar-2024	-	Shreedhar Reddy
02-Mar-2024	-	Gokaram Ramkrishna Balaji

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,679.65(+24.90/1.50%)	1,679.65	+24.90	76,550.07	129.29	37.15	3.97
Ipca Laboratories Ltd ₹1,336.30(-1.40/-0.10%)	1,336.30	-1.40	33,902.49	89.99	61.63	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,853.25(-36.65/-1.94%)	1,853.25	-36.65	28,761.48	77.76	56.76	10.71
Sanofi India Ltd ₹8,538.75(-85.50/-0.99%)	8,538.75	-85.50	19,664.74	53.32	33.29	19.36
IOL Chemicals & Pharmaceuticals Ltd ₹386.75(-8.80/-2.22%)	386.75	-8.80	2,270.44	-2.06	13.16	1.43

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.02	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.02	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	-0.90	-0.26	0.41	0.00	0.00	0.00
Total Income	-0.88	-0.26	0.41	0.00	0.00	0.00
Total Expenditure	1.32	1.02	1.61	8.60	0.69	0.54
PBIDT	-2.20	-1.28	-1.20	-8.60	-0.69	-0.54
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-2.20	-1.28	-1.20	-8.60	-0.69	-0.54
Depreciation	0.01	0.01	0.01	0.00	0.01	0.01
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.58	-0.78	0.09	-2.44	0.00	0.00
Reported Profit After Tax	-1.63	-0.50	-1.30	-6.16	-0.71	-0.55
Extra-ordinary Items	0.00	0.00	0.04	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.63	-0.50	-1.34	-6.16	-0.71	-0.55

EPS (Unit Curr.)	-0.76	-0.23	-0.61	-4.79	-0.54	-0.54
EPS (Adj) (Unit Curr.)	-0.76	-0.23	-0.61	-4.79	-0.54	-0.54
Calculated EPS (Unit Curr.)	-0.76	-0.24	-0.61	-2.87	-0.69	-0.53
Calculated EPS (Adj) (Unit Curr.)	-0.76	-0.24	-0.61	-2.87	-0.69	-0.53
Calculated EPS (Ann.) (Unit Curr.)	-3.05	-0.94	-2.43	-11.49	-2.75	-2.12
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-3.05	-0.94	-2.43	-11.49	-2.75	-2.12
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	21.44	21.44	21.44	21.44	10.27	10.27
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-11000.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	-11000.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	-8150.00	0.00	0.00	0.00	0.00	0.00

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.02	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.02	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	-0.90	-0.26	0.41	0.00	0.00	0.00
Total Income	-0.88	-0.26	0.41	0.00	0.00	0.00
Total Expenditure	1.32	1.02	1.61	8.60	0.69	0.54
PBIDT	-2.20	-1.28	-1.20	-8.60	-0.69	-0.54
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-2.20	-1.28	-1.20	-8.60	-0.69	-0.54
Depreciation	0.01	0.01	0.01	0.00	0.01	0.01
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.58	-0.78	0.09	-2.44	0.00	0.00
Reported Profit After Tax	-1.63	-0.50	-1.30	-6.16	-0.71	-0.55
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-1.63	-0.50	-1.30	-6.16	-0.71	-0.55

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.63	-0.50	-1.30	-6.16	-0.71	-0.55

EPS (Unit Curr.)	-0.76	-0.24	-0.61	0.00	-0.54	-0.05
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	21.44	21.44	21.44	21.44	10.27	10.27

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-11000.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	-11000.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	-8150.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	21.44	10.27	10.27	10.27	10.27	3.36
Reserves Total	0.63	-1.60	-1.74	-1.84	-1.87	-2.32
Equity Share Warrants	0.35	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	22.42	8.67	8.53	8.43	8.40	1.04
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	22.42	8.67	8.53	8.43	8.40	1.04
APPLICATION OF FUNDS :
Gross Block	0.12	0.51	0.51	0.51	0.46	0.00
Less : Accumulated Depreciation	0.02	0.48	0.47	0.42	0.39	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.10	0.03	0.04	0.09	0.07	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	2.00	0.45	0.45	0.45	0.45	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.27	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.89	0.37	0.00	0.00	0.00
Sundry Debtors	1.39	1.34	0.28	0.00	0.89	0.52
Cash and Bank	12.75	0.41	0.20	0.02	0.11	0.24
Loans and Advances	0.07	0.03	0.01	0.36	3.38	0.00
Total Current Assets	14.20	2.66	0.86	0.38	4.38	0.75
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.13	2.44	0.59	0.03	0.20	0.23
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	2.13	2.44	0.59	0.03	0.20	0.23
Net Current Assets	12.08	0.22	0.27	0.36	4.18	0.52
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	2.71	0.36	0.35	0.35	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.07	0.00
Net Deferred Tax	2.71	0.36	0.35	0.35	-0.07	0.00
Total Assets	20.17	1.06	1.11	1.24	4.64	0.52
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.41	0.20	0.02	0.11	0.24
Net Cash from Operating Activities	-4.02	-0.26	0.41	-0.75	-0.10
Net Cash Used In Investing Activities	-4.94	0.47	-0.23	0.66	0.00
Net Cash Used In Financing Activities	21.31	0.00	0.00	0.00	-0.03
Net Inc./Dec In Cash And Cash Equivalents	12.35	0.21	0.18	-0.09	-0.13
Cash And Cash Equivalents At End Of The Year	12.75	0.41	0.20	0.02	0.11

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

5.64%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

94.36%

**Promoter pledged shareholding 5.64%

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 124.43 crores. It has reported a sales of Rs. 0.02 crores and a net profit of Rs. -1.63 crores for the quarter ended December 2018. The company management includes Shankarappa Nagaraja Vinaya Babu, Venu Madhava Kaparthy,Mini Manikantan,Sadhanala Venkata Rao,P N Vijay,M Sudheer Anand,Methuku Nagesh,Shreedhara Shetty,Sadhanala Venkata Rao,Shankarappa Nagaraja Vinaya Babu (Pharmaids Pharmaceuticals Ltd) among others.

Chairman

Shankarappa Nagaraja Vinaya Babu

Registered office

4-4-211/212/3 1st Floor,Inderbagh Sulthan Bazar,Hyderabad,Telangana,500095

FAX :91-40-23232348

Background

Incorporation Year1989

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0